Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

被引：3
|
作者：
Alexander, Thomas [1 ]
Lacayo, Norman J. [2 ]
Pullarkat, Vinod A. [3 ]
Jabbour, Elias J. [4 ]
Khaw, Seong Lin [5 ]
Mullighan, Charles G. [6 ,7 ]
Bajel, Ashish [8 ]
Leonard, Jessica [9 ]
Norris, Robin [10 ]
Rubnitz, Jeffrey [11 ]
Vear, Susan I. [12 ]
Schmidt, Michelle [13 ]
Tong, Bo [13 ]
Zhou, Ying [13 ]
Ross, Jeremy A. [13 ]
Rosenwinkel, Lindsey [13 ]
Jacobson, Amanda [13 ]
Kim, Su Young [13 ]
Stock, Wendy [14 ]
机构：
[1] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
[2] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[3] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[5] Royal Childrens Hosp, Melbourne, Vic, Australia
[6] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA
[7] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA
[10] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[11] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
[12] Nationwide Childrens Hosp, Pediat Hematol & Oncol, Columbus, OH USA
[13] AbbVie Inc, N Chicago, IL USA
[14] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-113464
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3966
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Use of Bortezomib in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia
    Bello, Adriana
    Cortez, Rossana
    Collazo, Maylu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S269 - S270
  • [32] Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukemia
    Agthe, AG
    Dorffel, W
    Neuendank, A
    Hartmann, R
    Bruhmuller, S
    Klumper, E
    Pieters, R
    Veerman, AJP
    Henze, G
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 51 - 57
  • [33] Open-label, dose-escalation, phase 1 study of venetoclax in combination with navitoclax and chemotherapy in patients with relapsed acute lymphoblastic leukemia.
    Alexander, Thomas
    Khaw, Seong Lin
    Rubnitz, Jeffrey E.
    Vear, Susan I.
    Lacayo, Norman James
    Schmidt, Michelle
    Tong, Bo
    Rosenwinkel, Lindsey
    Bensman, Lindsey
    Verdugo, Maria
    Kim, Su Young
    Jabbour, Elias
    Stock, Wendy
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia
    Short, Nicholas J.
    Jabbour, Elias
    Jain, Nitin
    Senapati, Jayastu
    Nasr, Lewis
    Haddad, Fadi G.
    Li, Zhenhua
    Hsiao, Yu-Chih
    Yang, Jun J.
    Pemmaraju, Naveen
    Ohanian, Maro
    Wierda, William G.
    Montalban-Bravo, Guillermo
    Borthakur, Gautam
    Han, Lina
    Xiao, Lianchun
    Huang, Xuelin
    Abramova, Regina
    Zhao, Min
    Garris, Rebecca
    Konopleva, Marina
    Ravandi, Farhad
    Kantarjian, Hagop
    BLOOD ADVANCES, 2024, 8 (04) : 909 - 915
  • [35] Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia
    Guan, Wei
    Jing, Yu
    Dou, Liping
    Wang, Maoquan
    Xiao, Yang
    Yu, Li
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 855 - 861
  • [36] Safety of nelarabine in adults with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma
    Candoni, Anna
    Lazzarotto, Davide
    Petruzzellis, Giuseppe
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (07) : 751 - 756
  • [37] Nelarabine Combination Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Lymphoma/Leukemia
    Shimony, Shai
    Liu, Yiwen
    Valtis, Yannis K.
    Paolino, Jonathan D.
    Place, Andrew E.
    Brunner, Andrew M.
    Weeks, Lachelle D.
    Silverman, Lewis B.
    Vrooman, Lynda M.
    Neuberg, Donna S.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Luskin, Marlise R.
    BLOOD, 2022, 140 : 8989 - 8990
  • [38] Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
    Shimony, Shai
    Liu, Yiwen
    Valtis, Yannis K.
    Paolino, Jonathan D.
    Place, Andrew E.
    Brunner, Andrew M.
    Weeks, Lachelle D.
    Silverman, Lewis B.
    Vrooman, Lynda M.
    Neuberg, Donna S.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Luskin, Marlise R.
    BLOOD ADVANCES, 2023, 7 (07) : 1092 - 1102
  • [39] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
    Jeha, S
    Gaynon, PS
    Razzouk, BI
    Franklin, J
    Kadota, R
    Shen, V
    Litchtman-Jones, L
    Rytting, M
    Bomgaars, LR
    Rheingold, S
    Ritchey, K
    Albano, E
    Arceci, RJ
    Goldman, S
    Griffin, T
    Altman, A
    Gordon, B
    Steinherz, L
    Weitman, S
    Steinherz, P
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1917 - 1923
  • [40] CLOFARABINE FOLLOWED BY CYCLOPHOSPHAMIDE FOR TREATMENT OF RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS
    Malato, A.
    Santoro, A.
    Felice, R.
    Turri, D.
    Magrin, S.
    Di Bella, R.
    Scime, R.
    Salemi, D.
    Acquaviva, F.
    Fabbiano, F.
    HAEMATOLOGICA, 2012, 97 : 490 - 490
12345